Atanu Roy Chowdhury on LinkedIn: Jason Thatcher I had missed this in 2023, so I am making up for it in…
![PDF] Impact maturity times and citation time windows: The 2-year maximum journal impact factor | Semantic Scholar PDF] Impact maturity times and citation time windows: The 2-year maximum journal impact factor | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/db86e7759e7b862740e58dd455624a972a967147/19-Table1-1.png)
PDF] Impact maturity times and citation time windows: The 2-year maximum journal impact factor | Semantic Scholar
![PDF) Journal Impact Factor: 4.275 Global Impact factor of Journal: 0.876 Scientific Journals Impact Factor: 3.285 InfoBase Impact Factor: 3.66 PDF) Journal Impact Factor: 4.275 Global Impact factor of Journal: 0.876 Scientific Journals Impact Factor: 3.285 InfoBase Impact Factor: 3.66](https://i1.rgstatic.net/publication/353841122_Journal_Impact_Factor_4275_Global_Impact_factor_of_Journal_0876_Scientific_Journals_Impact_Factor_3285_InfoBase_Impact_Factor_366/links/6114de111e95fe241ac694b8/largepreview.png)
PDF) Journal Impact Factor: 4.275 Global Impact factor of Journal: 0.876 Scientific Journals Impact Factor: 3.285 InfoBase Impact Factor: 3.66
![PDF) Osmotic controlled drug delivery system (OSMO technology) and its impact on diabetes care | Dr. Mangesh Tiwaskar - Academia.edu PDF) Osmotic controlled drug delivery system (OSMO technology) and its impact on diabetes care | Dr. Mangesh Tiwaskar - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/72418766/mini_magick20211013-8014-vv2nyc.png?1634150826)
PDF) Osmotic controlled drug delivery system (OSMO technology) and its impact on diabetes care | Dr. Mangesh Tiwaskar - Academia.edu
![PDF) International Journal of Research in Pharmacy and Science Formulation Development and Assessment of Controlled Release Bilayered Osmotic Tablet Carrying Sulfonylurea Class - Anti Diabetic Agent & Imperative Factors Imparting Significant Impact PDF) International Journal of Research in Pharmacy and Science Formulation Development and Assessment of Controlled Release Bilayered Osmotic Tablet Carrying Sulfonylurea Class - Anti Diabetic Agent & Imperative Factors Imparting Significant Impact](https://i1.rgstatic.net/publication/341566913_International_Journal_of_Research_in_Pharmacy_and_Science_Formulation_Development_and_Assessment_of_Controlled_Release_Bilayered_Osmotic_Tablet_Carrying_Sulfonylurea_Class_-_Anti_Diabetic_Agent_Impera/links/5ec7778da6fdcc90d68ca91e/largepreview.png)